Active Juvenile Psoriatic Arthritis research hub

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

This study is looking into a medicine called apremilast for children and young people aged 5 to 17 who have a type of arthritis called juvenile psoriatic arthritis. It aims to see if this medicine works better than a dummy pill to reduce their arthritis symptoms.